NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
No Result
View All Result
Home ALL Healthcare

BioVaxys Further Expands Intellectual Property Portfolio in Global Markets

by Ed Johnson
October 29, 2021
A A

Files Applications for International Patent and Trademark Protection of CoviDTH

VANCOUVER, BC, October 28th, 2021 — BioVaxys Technology Corp. (CSE: BIOV), (FRA:5LB), (OTCQB:BVAXF) (“BioVaxys” or “Company”), announced today that it has broadened the patent coverage on CoviDTH, its T cell diagnostic for detecting an immune response to SARS-CoV-2, by filing an international patent application through the Patent Cooperation Treaty (“PCT”) for broad geographic market coverage outside the US. Although CoviDTH diagnostic results are intended to be visually interpreted by a trained technician or healthcare provider, additional patent claims include data capture and analysis via methods such as optical, infrared, and ultrasonic image processing.

The International Patent Cooperation Treaty (“PCT”) Application, which is a patent treaty with more than 150 member countries, makes it possible to seek patent protection for an invention simultaneously in a large number of countries by filing a single “international” patent application instead of filing several separate national or regional patent applications.

BioVaxys recently also filed international applications for registration of the CoviDTH trademark in selected markets including Canada, Mexico, European Union and United Kingdom. Six months ago, the Company filed its application with the United States Patent and Trademark Office (“USPTO”) for U.S. registration of its “CoviDTH” trademark. Trademark applications in certain countries may be treated as if they had been filed on the filing date of the U.S. application, provided the applications are filed within six months of the U.S. filing date.  BioVaxys may still apply for trademark registration of CoviDTH in other countries at a later date, but it will be without the benefit of the earlier U.S. filing date.

BioVaxys CEO James Passin states “Given the urgent importance of commercializing a low-cost diagnostic for T cell immunity to Covid-19 in the context of the global pandemic, we believe that it critical to protect Intellectual Property in key international markets as we continue to advance to towards the submission of an IND in the United States.”

For greater certainty, BioVaxys is not making any express or implied claims that it has the ability to treat the SAR-CoV-2 virus at this time.

Tags: < Partnership
ShareTweetShareSend

Related Industries

Healthcare

Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.

September 20, 2023
Healthcare

BD Ranks in Top 10 for Transparency, Awarded Best Code of Conduct in 2023 U.S. Transparency Awards

September 20, 2023
Healthcare

Celanese Announces Agreement with the Population Council for Sustained Release Dual-API Therapeutic

September 13, 2023
Healthcare

Thermo Fisher Scientific and National Minority Quality Forum Collaborate to Make Clinical Research More Accessible to Historically Underserved Communities

September 8, 2023
Healthcare

Abbott to Acquire Bigfoot Biomedical, Furthering Efforts to Develop Personalized, Connected Solutions for People with Diabetes

September 6, 2023
Healthcare

AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION

September 2, 2023

Rockwell Automation and Infinitum Announce Agreement to Make High-Efficiency Low Voltage Drives and Motors Available for Energy-Intensive Industrial Applications

September 15, 2023

...

Intel, Tower Semiconductor logos

Intel Foundry Services and Tower Semiconductor Announce New US Foundry Agreement

September 6, 2023

...

Mastercard SpendingPulse: U.S. Retail Sales Expected to Grow 3.7%* This Holiday Season

September 20, 2023

...

IBM Announced as a Sponsor of 2023 U.N. Climate Change Conference (COP28)

September 14, 2023

...

Ford Launches Home Charging Pilot Program with Duke Energy for EV Customers to Save Money and Support Grid Sustainability

August 29, 2023

...

Celanese Announces Agreement with the Population Council for Sustained Release Dual-API Therapeutic

September 13, 2023

...

Honeywell Partners With National Renewable Energy Lab On Hydrogen Fuel Storage

September 13, 2023

...

chevron acquires majority stake in the advanced clean energy storage hydrogen project in delta, utah

September 13, 2023

...

BMW, Ford and Honda Agree to Create ChargeScape, a New Company Focused on Optimizing Electric Vehicle Grid Services

September 13, 2023

...

NORTH AMERICAN BUSINESS (www.na-biz.com) is a leading source of business and corporate news, information, industry trends, market updates and insights across a broad spectrum of industries in North America and worldwide.

MENU

  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

CONTACT US

EDITORIAL:     editor#na-biz.com

PARTNERSHIP:     biz#na-biz.com

HUMAN RESOURCE:     hr#na-biz.com

* (replace # with @)

  • Official Site

Copyright © NORTH AMERICAN BUSINESS All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © NORTH AMERICAN BUSINESS All rights reserved.